Gemcitabine/carboplatin (GC) vs. carboplatin (C) in platinum sensitive recurrent ovarian cancer (OVCA).: Results of a Gynecologic Cancer Intergroup randomized phase III trial of the AGO OVAR, the NCICCTG and the EORTC GCG. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pfisterer, J
  • Plante, M
  • Vergote, I
  • Du Bois, A
  • Wagner, U
  • Hirte, Holger
  • Lacave, AJ
  • Stähle, A
  • Kimmig, R
  • Eisenhauer, E

publication date

  • July 15, 2004